Shockwave Medical (SWAV) Misses Q2 EPS by 7c

Shockwave Medical (NASDAQ: SWAV) reported Q2 EPS of $0.76, $0.07 worse than the analyst estimate of $0.83. Revenue for the quarter came in at $180.2 million versus the consensus estimate of $173.79 million.

For earnings history and earnings-related data on Shockwave Medical (SWAV) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• Baird starts Abbott at Outperform, sees product pipeline driving growth
• NHC acquires 35 facilities from NHI for $560 million